default author photo

Benjamin D. Greenbaum

Memorial Sloan Kettering Cancer Center

New York, NY 10065

United States

  • Memorial Sloan Kettering Cancer Center

SCHOLARLY PAPERS

3

DOWNLOADS

99

TOTAL CITATIONS

0

Scholarly Papers (3)

Actions:
Email selected abstracts
1.

Tissue-Specific Landscape of the Human T Cell Repertoire in Graft-Versus-Host Disease

Number of pages: 68 Posted: 16 Feb 2022
Susan DeWolf, Katherine Nichols, Yuval Elhanati, Chi L. Nguyen, Nicholas R. Waters, Natasia Rodriguez, Paul A. Giardina, John B. Slingerland, Hana Andrlová, Rajya Kappagantula, Yanyun Li, Priscilla Baez, Rajmohan Murali, Akimasa Hayashi, Nicole Lee, Anqi Dai, Anastasia I. Kousa, Amanda G. Blouin, Doris M. Ponce, Heather J. Landau, Ioannis Politikos, Roni Tamari, Alan M. Hanash, Robert R. Jenq, Sergio A. Giralt, Kate A. Markey, Yanming Zhang, Miguel-Angel Perales, Nicholas D. Socci, Benjamin D. Greenbaum, Christine Iacobuzio-Donahue, Travis J. Hollmann, Marcel R.M. van den Brink and Jonathan U. Peled
Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center - Computational Oncology Service, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center - Sloan Kettering Institute, Immunology Program, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center - Adult Bone Marrow Transplantation Service, Fred Hutchinson Cancer Research Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center - Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center - Department of Pathology, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center - Adult Bone Marrow Transplantation Service and Memorial Sloan Kettering Cancer Center
Downloads 53 (1,031,043)

Abstract:

Loading...

T cell repertoire, graft-versus-host disease, tissue-resident T cells, hematopoietic cell 
transplantation

2.

Impaired Humoral Immunity Is Associated With Prolonged COVID-19 Despite Robust CD8 T-Cell Responses

Number of pages: 54 Posted: 11 Mar 2022
Olga Lyudovyk, Justin Y. Kim, David Qualls, Madeline A. Hwee, Sawsan R. Boutemine, Yuval Elhanati, Alexander Solovyov, Melanie Douglas, Eunise Chen, Ngolela Esther Babady, Lakshmi Ramanathan, Pallavi Vedantam, Sigrid Gouma, Philip Wong, Scott E. Hensley, Benjamin D. Greenbaum, Alexander Huang and Santosha Adipudi Vardhana
Memorial Sloan Kettering Cancer Center, University of Pennsylvania, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center - Computational Oncology Service, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, University of Texas at Houston - McGovern Medical School, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, University of Pennsylvania, Memorial Sloan Kettering Cancer Center, University of Pennsylvania - Department of Microbiology, Memorial Sloan Kettering Cancer Center, University of Pennsylvania - Division of Hematology/Oncology and Memorial Sloan Kettering Cancer Center - Lymphoma Service
Downloads 29 (1,332,057)

Abstract:

Loading...

cancer, COVID-19, SARS-CoV-2, T-cell, B-cell, CD20, rituximab

3.

Spatially Organized Dendritic Cell–t Cell Interactions Are Associated With Response to Cd40 Agonism in Non-muscle Invasive Bladder Cancer

Number of pages: 47 Posted: 14 Apr 2026
Juan Carlos Osorio, Lucas Blanchard, Ning Yao, Syed M. Alam, Ali Ghasemzadeh, Karissa Whiting, Venkatraman E Seshan, Andrew Mijacika, Carlo Sevilla, Juan Angulo-Lozano, Ved P. Sharma, Morgan Tomberlin, Melissa McCarter, Jessica Pfau, Jeffrey L. Wong, David Knorr, Timothy F. Donahue, Robert Smith, Eugene J. Pietzak, Benjamin D. Greenbaum, Hikmat A. Al-Ahmadie, Jonathan E. Rosenberg, Jeffrey Ravetch and Bernard H. Bochner
Rockefeller University - Laboratory of Molecular Genetics and Immunology, Rockefeller University - Laboratory of Molecular Genetics and Immunology, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center - Department of Epidemiology and Biostatistics, Rockefeller University - Laboratory of Molecular Genetics and Immunology, Memorial Sloan Kettering Cancer Center, affiliation not provided to SSRN, Rockefeller University - Laboratory of Molecular Genetics and Immunology, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center - Department of Medicine, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Rockefeller University - Laboratory of Molecular Genetics and Immunology and Memorial Sloan Kettering Cancer Center
Downloads 17 (1,481,165)

Abstract:

Loading...

CD40, Fc Receptor, non-muscle invasive bladder cancer, immune triads, tertiary lymphoid structures, dendritic cells, BCG, cancer immunotherapy, antibody, clinical trial